slides · global inventory
Callout
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 41,369
Current window 30,811-30,840
Pages 1,379
Rows per page 30
Component
30,811-30,840 of 41,369
30
Uses a combination of TSR performance and deal premium benchmarking to expose the 'trough' valuation.Altair US LLC | Activist Presentation Deck | 38 slides · Altair US, LLC
Activist deck Activist investor Beat · Solution1 hit
31
Uses a 'true undisturbed price' argument to challenge the fairness opinion's baseline.Altair US LLC | Activist Presentation Deck | 38 slides · Altair US, LLC
Activist deck Activist investor Beat · Solution1 hit
36
Includes three news clippings as evidence of recent deal activity.Altair US LLC | Activist Presentation Deck | 38 slides · Altair US, LLC
Activist deck Activist investor Beat · Solution1 hit
37
Altair US LLC | Activist Presentation Deck | 38 slidesAltair US LLC | Activist Presentation Deck | 38 slides · Altair US, LLC
Activist deck Activist investor Beat · Solution1 hit
03
Includes logos for AMMO, STELTH, STREAK, and GunBroker.com.AMMO | Investor Presentation Deck | 27 slides · AMMO, Inc.
Pitch deck Investor relations Beat · Problem1 hit
04
The slide uses a horizontal timeline with callout boxes for specific events.AMMO | Investor Presentation Deck | 27 slides · AMMO, Inc.
Pitch deck Investor relations 1 hit
10
The chart uses a stacked bar approach to show captured vs. estimated visits, with trend lines indicating growth rates.Anebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slides · Anebulo Pharmaceuticals
Conference presentation Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
11
Anebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slidesAnebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slides · Anebulo Pharmaceuticals
Conference presentation Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
14
Uses a before-after visual comparison to explain the mechanism of action.Anebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slides · Anebulo Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
23
The slide uses a process flow diagram to illustrate the randomized, double-blind, placebo-controlled study structure.Anebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slides · Anebulo Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
31
The slide uses a flow diagram to illustrate the randomized, double-blind, placebo-controlled study structure.Anebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slides · Anebulo Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
32
The slide uses a process flow diagram to illustrate the clinical trial methodology.Anebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slides · Anebulo Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
03
The slide uses a three-column structure to summarize the company's value proposition.Apexigen | Investor Presentation Deck | 27 slides · Apexigen
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
09
The slide uses a comparative framework to position the drug as a superior alternative to existing checkpoint inhibitors.Apexigen | Investor Presentation Deck | 27 slides · Apexigen
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
10
The slide uses a diagram of an antibody to map specific functional regions to their biological mechanisms.Apexigen | Investor Presentation Deck | 27 slides · Apexigen
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
12
The slide uses a simple additive framework to show how immune response and clinical activity lead to a strategic positioning as a 'backbone' therapy.Apexigen | Investor Presentation Deck | 27 slides · Apexigen
Pitch deck Investor relations Beat · Traction1 hit
15
Spider plot (swimmer plot variant) showing individual patient responses over time.Apexigen | Investor Presentation Deck | 27 slides · Apexigen
Pitch deck Investor relations Beat · Traction1 hit
16
The slide uses a before-and-after medical imaging comparison to validate clinical efficacy.Apexigen | Investor Presentation Deck | 27 slides · Apexigen
Pitch deck Investor relations Beat · Traction1 hit
17
Includes Kaplan-Meier survival curve and comparative efficacy tables.Apexigen | Investor Presentation Deck | 27 slides · Apexigen
Pitch deck Investor relations Beat · Traction1 hit
18
Includes a timeline of biopsy (Bx) and treatment, and paired dot plots showing pre/post treatment changes in CD68+ and CD3+ cell counts.Apexigen | Investor Presentation Deck | 27 slides · Apexigen
Pitch deck Investor relations Beat · Traction1 hit
19
Spider plot (swimmer plot variant) showing individual patient tumor response trajectories.Apexigen | Investor Presentation Deck | 27 slides · Apexigen
Pitch deck Investor relations Beat · Traction1 hit
22
The slide uses a biological process diagram to illustrate the mechanism of action.Apexigen | Investor Presentation Deck | 27 slides · Apexigen
Pitch deck Investor relations 1 hit
25
The slide uses a three-pillar structure supported by a foundational platform.Apexigen | Investor Presentation Deck | 27 slides · Apexigen
Pitch deck Investor relations 1 hit
05
The chart uses a dual-line comparison to show the divergence in risk outcomes based on treatment timing.Aquestive Therapeutics | Results Presentation Deck | 14 slides · Aquestive Therapeutics
Deck Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
12
Aquestive Therapeutics | Results Presentation Deck | 14 slidesAquestive Therapeutics | Results Presentation Deck | 14 slides · Aquestive Therapeutics
Deck Investor relations Beat · Solution (Provide relief)1 hit
07
The slide uses a visual comparison of biological mechanisms to argue for the superiority of the company's 'Decoy AXL Receptor' approach.Aravive | Investor Presentation Deck | 39 slides · Aravive
Pitch deck Investor relations Beat · Agitate (Make it worse)1 hit
08
The slide uses a two-column layout to contrast the drug's engineering/profile with its biomarker/IP strategy.Aravive | Investor Presentation Deck | 39 slides · Aravive
Pitch deck Investor relations Beat · Agitate (Make it worse)1 hit
06
The slide uses iconography to represent key statistics about rare diseases.AstraZeneca | Investor Day Presentation Deck | 49 slides · AstraZeneca
Conference presentation Investor relations Beat · Problem & ComplicationLoop · Golden Circle1 hit
12
The slide uses a biological process flow to explain the therapeutic rationale for C5 inhibition.AstraZeneca | Investor Day Presentation Deck | 49 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution & ApproachLoop · Mece Breakdown1 hit
18
Includes 'Number at risk' table below the x-axis.AstraZeneca | Investor Day Presentation Deck | 49 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution & ApproachLoop · Mece Breakdown1 hit